Skip to main content

Showing results for Alzheimer's disease

IU School of Medicine continues record-setting research trend; up 5 spots in National Institutes of Health rankings

­INDIANAPOLIS – For the fourth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, demonstrating national leadership in critical fields like Alzheimer’s disease and pediatrics and providing a major boost to the Indiana economy. IU School of Medicine scientists and physicians were awarded over […]

IU School of Medicine  |  Jan 28, 2020

First randomized clinical trial found no harms from dementia screening in primary care

INDIANAPOLIS – Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia. The researchers found no harm, as measured by patient reported depressive and anxiety symptoms, from screening for Alzheimer’s disease and related dementia in diverse […]

IU School of Medicine  |  Jan 15, 2020

IU School of Medicine awarded $36 million NIH grant for Alzheimer's disease drug discovery center

INDIANAPOLIS — Indiana University School of Medicine has been awarded a grant expected to total $36 million over five years from the National Institutes of Health to launch a drug discovery center to accelerate the development of promising treatments for Alzheimer’s disease. The center is a strategic partnership with the Purdue Institute for Drug Discovery. […]

IU School of Medicine  |  Oct 01, 2019

Alzheimer’s Association Greater Indiana Chapter announces $1 million grant for LEADS study

Indianapolis, IN – August 19, 2019 – The Alzheimer’s Association Greater Indiana Chapter today announced it is funding a $1 million add-on study focusing on genetics to the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) led by Indiana University School of Medicine. The additional funding will allow researchers to study the entire genome of all 600 […]

IU School of Medicine  |  Aug 19, 2019

Novel discovery of links between liver dysfunction and Alzheimer’s disease

New research from the Alzheimer’s Disease Metabolomics Consortium (ADMC) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) has uncovered novel connections between liver dysfunction and Alzheimer’s disease (AD), paving a new path toward a systems level view of Alzheimer’s relevant for early detection and ultimately for prevention. The study, published today in JAMA Network Open, was led […]

Katie Duffey  |  Jul 31, 2019

Researchers discover hidden differences between pathology of CTE and Alzheimer’s disease

INDIANAPOLIS — An international team of scientists at Indiana University School of Medicine, University of Kansas and the U.K. Medical Research Council have dismantled the belief that Alzheimer’s disease and Chronic Traumatic Encephalopathy have identical pathology. Their discovery offers options for improved diagnosis and potential targeted treatments. CTE has been making headlines across the sports […]

Christine Drury  |  Mar 20, 2019

IU-led study of younger Alzheimer’s patients aims to pave the way toward new treatments

INDIANAPOLIS — Indiana University School of Medicine scientists have received the university’s largest single grant from the National Institutes of Health and will partner with a team of premier researchers around the country to lead a five-year national research study of a relatively rare form of Alzheimer’s disease. Researchers hope the study will provide a […]

IU School of Medicine  |  Oct 04, 2018

IU announces progress toward its Precision Health Grand Challenge: cancers it aims to cure, diseases it is working to prevent

Indiana University researchers and physicians announced progress toward their bold goals of developing cures and preventive treatments for devastating diseases prevalent among Indiana residents.

IU School of Medicine  |  Aug 06, 2018

NIH funds major biobank expansion at IU School of Medicine to support Alzheimer’s disease research

With a grant from the National Institute of Health’s National Institute on Aging, Indiana University School of Medicine will dramatically increase the size and scope of the biobank that stores DNA and other biological samples used by researchers globally to better understand, treat and hopefully cure Alzheimer’s disease. The grant is expected to last three years and total $12 million pending the availability of funds.

IU School of Medicine  |  Jul 21, 2018

Expansion of Alzheimer's disease biospecimens repository prompts name change

Indiana University School of Medicine’s repository for biological samples used by the nation’s Alzheimer’s disease researchers is changing its name to the National Centralized Repository for Alzheimer’s Disease and Related Dementias.

IU School of Medicine  |  Jul 20, 2018